FDA authorizes new over-the-counter eye drop for redness relief

The FDA has approved Brytly (apraclonidine ophthalmic solution, 0.125%) as a new nonprescription eye drop. This marks the first over-the-counter eye drop containing apraclonidine, intended to relieve eye redness from minor irritations. The approval aims to broaden consumer access to effective nonprescription treatments.